TerrAscend (TSNDF) Receivables (2021 - 2026)
TerrAscend's (TSNDF) quarterly Receivables came in at $17.2 million in Q1 2026, down 16.14% year-on-year from $20.5 million in Q1 2025, and down 2.19% on a QoQ basis from $17.6 million in Q4 2025.
TerrAscend (TSNDF) Receivables (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Receivables data on file, last reported at $17.2 million in Q1 2026.
- On a quarterly basis, Receivables fell 16.14% year-over-year to $17.2 million in Q1 2026; TTM through Mar 2026 was $17.2 million, a 16.14% decrease from a year earlier, with the FY2025 full-year figure at $17.6 million, down 15.52% from the prior year.
- Receivables for Q1 2026 stood at $17.2 million, down from $17.6 million in the prior quarter.
- Over the last five years, Receivables for TSNDF reached as high as $40.4 million in Q4 2022 and fell as low as $16.1 million in Q3 2023.
- Historically, Receivables has averaged $20.5 million across 5 years, with a median of $19.6 million in 2023.
- Across the five-year window, Receivables soared 213.87% in 2022 and tumbled 49.97% in 2023, its largest moves.
- Year by year, Receivables stood at $40.4 million in 2022, then tumbled by 49.97% to $20.2 million in 2023, then grew by 2.9% to $20.8 million in 2024, then slipped by 15.52% to $17.6 million in 2025, then dropped by 2.19% to $17.2 million in 2026.
- Per Business Quant data, the three most recent Receivables figures were $17.2 million in Q1 2026, $17.6 million in Q4 2025, and $17.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 17.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.18 Mn |
| Dec 31, 2025 | 17.56 Mn |
| Sep 30, 2025 | 17.65 Mn |
| Jun 30, 2025 | 20.32 Mn |
| Mar 31, 2025 | 20.48 Mn |
| Dec 31, 2024 | 20.79 Mn |
| Sep 30, 2024 | 17.75 Mn |
| Jun 30, 2024 | 17.34 Mn |
| Mar 31, 2024 | 17.90 Mn |
| Dec 31, 2023 | 20.20 Mn |
| Sep 30, 2023 | 16.10 Mn |
| Jun 30, 2023 | 20.21 Mn |
| Mar 31, 2023 | 19.64 Mn |
| Dec 31, 2022 | 40.38 Mn |
| Sep 30, 2022 | 18.40 Mn |
| Jun 30, 2022 | 22.78 Mn |
| Mar 31, 2022 | 23.70 Mn |
| Dec 31, 2021 | 12.87 Mn |